| Companies sponsors |
AbbVie (upadacitinib) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
NHS Northern, Eastern and Western Devon CCG |
| |
NHS Windsor, Ascot and Maidenhead CCG |
| |
Welsh Government |
| Patient carer groups |
Bladder and Bowel Community |
| |
Bowel Cancer UK |
| |
Colostomy UK |
| |
Crohn’s and Colitis UK |
| |
GUTS UK |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
Ulcerative Colitis UK |
| Professional groups |
Association of Coloproctology for Great Britain and Ireland |
| |
British Geriatrics Society |
| |
British Society of Gastroenterology |
| |
Neonatal & Paediatric Pharmacist Group |
| |
Primary Care Society for Gastroenterology |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal Society of Medicine |
| |
Royal Pharmaceutical Society |
| |
UK Clinical Pharmacy Association |
| Comparator companies |
AbbVie (adalimumab) |
| |
Amgen (adalimumab) |
| |
Biogen Biosimilars (adalimumab, infliximab) |
| |
Bristol-Myers Squibb Pharmaceuticals (ozanimod) |
| |
Celltrion Healthcare UK (adalimumab, infliximab) |
| |
Fresenius Kabi (adalimumab) |
| |
Galapagos Biotech (filgotinib) |
| |
Gilead Sciences (filgotinib) |
| |
Janssen-Cilag (ustekinumab) |
| |
Merck Sharp & Dohme (golimumab, infliximab) |
| |
Pfizer (infliximab, tofacitinib) |
| |
Sandoz (adalimumab, infliximab) |
| |
Takeda UK (vedolizumab) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare Products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Scottish Society of Gastroenterology |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group |
| |
Cochrane UK |
| |
Genomics England |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health Research |